Packer Rowena M A, Hobbs Sarah L, Blackwell Emily J
Royal Veterinary College, London, United Kingdom.
Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.
Front Vet Sci. 2019 Jan 28;6:3. doi: 10.3389/fvets.2019.00003. eCollection 2019.
Epilepsy is a common, complex and often challenging neurological disorder to treat in the dog, with 20-30% of dogs resistant to conventional medical therapies, and associated with cognitive and behavioral comorbidities and early death. Behavioral interventions are an emerging area of focus in the adjunctive treatment of drug-resistant human epilepsy patients, with studies indicating positive effects of a variety of interventions including relaxation-based techniques and behavioral therapy interventions. Behavioral interventions have the potential not only to improve seizure control, but also improve behavioral comorbidities and general quality of life in this hard to treat patient group. Despite striking similarities between human and canine epilepsy patients, including the recognition of co-morbid anxiety in epilepsy patients, behavioral interventions have yet to be studied in dogs. This is compounded by several licensed psychopharmaceutical agents for dogs being contra-indicated in epilepsy patients. We present evidence from human studies of the efficacy of behavioral interventions to improve seizure control, psychiatric comorbidities and quality of life, and propose that adapting such interventions for canine patients may be a valuable addition to the epilepsy management toolkit. There is a need for multi-center, double-blinded, placebo-controlled trials to confirm the effects of behavioral interventions on seizure frequency in veterinary medicine. In the absence of such evidence to date, the use of established behavioral medicine techniques to reduce stress and improve the mental health of these often sensitive and challenging patients is advocated, with a greater role for behaviorists in the management of epilepsy patients alongside neurologists and general practitioners.
癫痫是犬类常见、复杂且治疗往往具有挑战性的神经系统疾病,20%至30%的犬对传统药物治疗耐药,且与认知和行为共病以及早逝相关。行为干预是耐药性人类癫痫患者辅助治疗中一个新兴的重点领域,研究表明包括基于放松的技术和行为治疗干预在内的多种干预措施具有积极效果。行为干预不仅有可能改善癫痫控制,还能改善这一难以治疗的患者群体的行为共病和总体生活质量。尽管人类和犬类癫痫患者之间存在显著相似之处,包括认识到癫痫患者存在共病焦虑,但行为干预在犬类中的研究尚未开展。此外,几种犬用许可精神药物在癫痫患者中属禁忌药物,这使情况更加复杂。我们展示了来自人类研究的证据,证明行为干预在改善癫痫控制、精神共病和生活质量方面的疗效,并提出将此类干预措施应用于犬类患者可能是癫痫管理工具包中的一项有价值补充。需要进行多中心、双盲、安慰剂对照试验,以确认行为干预对兽医学中癫痫发作频率的影响。鉴于目前尚无此类证据,提倡使用既定的行为医学技术来减轻压力并改善这些通常敏感且具有挑战性的患者的心理健康,行为学家在癫痫患者管理中应与神经科医生和全科医生发挥更大作用。